Francesco Vermiglio

Dr. Francesco Vermiglio


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in Journal of Clinical & Translational Endocrinology
Verified
Journal Article
Open access
MMMariacarla Moleti
Mariacarla Moleti
MMMaria Di Mauro
Maria Di Mauro
GSGiacomo Sturniolo
Giacomo Sturniolo
MRMarco Russo
Marco Russo
FVFrancesco Vermiglio
Francesco Vermiglio
Hyperthyroidism during pregnancy is uncommon. Nonetheless, prompt identification and adequate management of hyperthyroidism in a pregnant woman is essential, because uncontrolled thyrotoxicosis significantly increases the risk of maternal and fetal complications. Also, fetal prognosis may be affected by the transplacental passage of maternal thyroid stimulating antibodies or thyrostatic agents, both of which may disrupt fetal thyroid function. Birth defects have been reported in association with the use of antithyroid drugs during early pregnancy. Although rarely, offspring of mothers with Graves' disease may develop fetal/neonatal hyperthyroidism, the management of which requires a close collaboration between endocrinologists, obstetricians, and neonatologists. Because of the above considerations, the management of pregnant and lactating women with hyperthyroidism requires special care, bearing in mind that both maternal thyroid excess per se and related treatments may adversely affect the newborn's health. In this review we discuss the diagnosis and management of hyperthyroidism in pregnancy, along with the impact of thyrotoxicosis and medications on fetal outcome.

1 February 2016 in Thyroid®
Verified
Journal Article
Closed access
MMMariacarla Moleti
Mariacarla Moleti
FTFrancesco Trimarchi
Francesco Trimarchi
GTGaetano Tortorella
Gaetano Tortorella
ALAlice Candia Longo
Alice Candia Longo
GGGrazia Maria Giorgianni
Grazia Maria Giorgianni
FVFrancesco Vermiglio
Francesco Vermiglio
Background and Objective: Maternal iodine nutrition and thyroid status may influence neurocognitive development in offspring. This study investigated the effects on the intelligence quotient (IQ) of children born to mothers with different levels of iodine supplementation, with or without the administration of levothyroxine (LT4), prior to and during pregnancy. Patients and Methods: This pilot, prospective, observational study included four study groups, each comprising 15 mother–child pairs, identified on the basis of maternal histories of iodized salt consumption and LT4 treatment prior to and during pregnancy. The groups were labeled as follows: iodine (I), no iodine (no-I), iodine + LT4 (I + T4), and no iodine + LT4 (no-I + T4). IQ tests were administered to children at 6–12 years of age with the Wechsler Intelligence Scale for Children–3rd Edition (WISC-III), with full-scale IQ (FSIQ), verbal IQ (VIQ), and performance IQ (PIQ) being evaluated. Results: Children of I and I + T4 mothers had similar verbal, performance, and FSIQs, which were 14, 10, and 13 points higher, respectively, than children born to no-I and no-I + T4 mothers. A positive association was found between VIQ and maternal urinary iodine (β = 1.023 [confidence interval (CI) 1.003–1.043]; p = 0.028), but not with maternal free thyroxine concentrations at any stage of pregnancy. Overall, the prevalence of borderline or defective cognitive function was more than threefold higher in the children of mothers not using iodized salt than of those mothers using it (76.9% vs. 23.1%, odds ratio 7.667 [CI 2.365–24.856], χ 2 = 12.65; p = 0.0001). Conclusions: Neuro-intellectual outcomes in children appear to be more dependent on their mothers' nutritional iodine status than on maternal thyroid function. These results support the growing body of evidence that prenatal, mild-to-moderate iodine deficiency adversely affects cognitive development later in life, with a seemingly greater impact on verbal abilities.

19 May 2015 in Endocrine
Verified
Journal Article
Closed access
PDF file
GSGiacomo Sturniolo
Giacomo Sturniolo
MVMaria Antonia Violi
Maria Antonia Violi
BGBruno Galletti
Bruno Galletti
SBSergio Baldari
Sergio Baldari
ACAlfredo Campennì
Alfredo Campennì
MMMariacarla Moleti
Mariacarla Moleti

22 March 2016 in Endocrine
Verified
Journal Article
Closed access
PDF file
MMMariacarla Moleti
Mariacarla Moleti
GGGiuseppe Giuffrida
Giuseppe Giuffrida
GSGiacomo Sturniolo
Giacomo Sturniolo
Giovanni SquadritoGiovanni Squadrito
Giovanni Squadrito
ACAlfredo Campennì
Alfredo Campennì
Michele MarinoMichele Marino
Michele Marino

3 May 2021 in Thyroid®
Verified
Journal Article
Closed access
SASimona De Angelis
Simona De Angelis
MBMarcello Bagnasco
Marcello Bagnasco
MMMariacarla Moleti
Mariacarla Moleti
CRConcetto Regalbuto
Concetto Regalbuto
MTMassimo Tonacchera
Massimo Tonacchera
AOAntonella Olivieri
Antonella Olivieri
Background: The frequency of overweight (OW) and obese (OB) children has increased worldwide, particularly in economically developed countries. No studies have been conducted to verify whether the increasing frequency of OW and obesity in schoolchildren may affect the evaluation of iodine nutritional status in populations. The aim of this study was to verify whether urinary iodine concentration (UIC), thyroid volume (TV), and thyroid hypoechoic pattern may be affected by body mass index (BMI) in schoolchildren. Methods: The children included in this study (aged 11–13 years) were a part of the schoolchildren recruited in the second nationwide survey (period 2015–2019) conducted in Italy to monitor by law (Atto di Intesa Stato-Regioni February 26, 2009) the nationwide iodine prophylaxis program. Specifically, 1281 schoolchildren residing in iodine-sufficient areas (IS group) and 384 children residing in a still mildly iodine-deficient area (ID group) were recruited between January and March 2015 in the first-degree secondary state schools. In all the children, spot UIC was measured, thyroid ultrasound was performed to evaluate TV, and hypoechogenicity was assessed to indirectly evaluate iodine-associated thyroid autoimmunity. Results: The frequency of OW, OB, and adequate weight (AW) children was similar in the IS and ID groups at any age. After adjusting for sex and age, the regression analysis showed lower UIC values in OB children than in AW children of the IS group (beta coefficient = −34.09 [95% confidence interval −65.3 to −2.8]), whereas no significant differences were observed in the ID group. In both the IS and ID groups, the distribution of TV in AW children was significantly shifted toward lower values in comparison to the distribution of OB children ( p < 0.001 in the IS group; p = 0.012 in the ID group). Furthermore, the frequency of thyroid hypoechogenicity was higher in the ID group than in the IS group (10.9% vs. 6.6%, p = 0.005); however, in both groups, it was significantly lower in AW children than in OB children ( p < 0.01). Conclusions: This study for the first time demonstrates that BMI may be a confounding factor in monitoring iodine nutritional status in schoolchildren. Since in Italy as in other Western countries the number of OW and OB children is high, BMI is a factor to consider in monitoring salt iodization programs worldwide.

17 January 2018 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
GZGiuseppina Zirilli
Giuseppina Zirilli
LCLaura Cannavò
Laura Cannavò
FVFrancesco Vermiglio
Francesco Vermiglio
MVMaria Antonia Violi
Maria Antonia Violi
FLFilippo De Luca
Filippo De Luca
Malgorzata WasniewskaMalgorzata Wasniewska
Malgorzata Wasniewska
The available studies concerning the influence of age on the phenotypical expression of differentiated thyroid carcinoma (DTC) have hitherto compared DTC presentation either between pre-pubertal and pubertal children or between pediatric patients and aged adults; aim of this study was to ascertain for the first time whether presentation of DTC may significantly vary according to age, even within a peculiar study population covering only young patients aged less than 30 years. The main clinical, biochemical and pathologic data at DTC diagnosis were retrospectively recorded in 2 selected cohorts including, respectively, 18 children and adolescents aged less than 18 years (Group A) or 45 young adults aged between 20 and 29.8 years (Group B). The statistical distribution of DTC cases in the different age ranges was found to progressively increase with increasing age; furthermore, the patients of Group A exhibited at diagnosis a more severe clinical involvement and a higher rate of extra-regional metastases; finally, also the association with both autoimmune thyroid diseases (AITDs) and a biochemical hypothyroid pattern was more common in Group A patients. In a study population younger than 30 years: a) the risk of developing DTC increases with age, achieving its zenith during the 3rd decade of life; b) clinical presentation is more severe in children and adolescents younger than 18 years than in the patients aged between 20 and 30; c) in the cohort of children and adolescents DTC is more often associated with AITDs, which might play some role in conditioning the more aggressive phenotypical presentation of DTC in this patient group.